greatest potential impact,0.37476
quarter worth,0.28805
Management Holdings LLC.,0.563848
price target,0.432428
Raptor Pharmaceutical Corp.,-0.0678211
stock,0.144972
consensus price target,0.45302
neurodegenerative disorders,-0.832433
hold rating,-0.219936
Cornerstone Capital Management,0.563848
clinical development,0.291437
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.464711
nephropathic cystinosis,0.331552
sell rating,0.279465
Globeflex Capital,0.410956
personal trading style,0.598412
PROCYSBI delayed-release capsules,0.371668
average rating,-0.308539
buy rating,-0.219936
Investment Management Inc.,0.662013
Capital Management Holdings,0.563848
Market Beat.com reports,-0.212917
average price,0.414263
new treatment options,0.767042
shares,0.548976
non-opioid solution,-0.811622
concise daily summary,0.446535
Asset Management L.P.,0.559086
company,0.0101461
Schwab Charles Investment,0.662013
potentially thrombotic disorder,-0.811622
rating,0.0961807
Charles Investment Management,0.662013
TFS Capital LLC,0.28805
drug targeting platforms,0.767042
formulation expertise,0.767042
new stake,0.28805
